Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis

Jiann-Hwa Chen, Chia-Chi Wang, I-Shiang Tzeng

Open source

DOI
10.1016/j.ctarc.2026.101422
Published
2026
Container
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101422,
  title = {Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis},
  author = {Jiann-Hwa Chen and Chia-Chi Wang and I-Shiang Tzeng},
  year = {2026},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2026.101422},
  url = {https://doi.org/10.1016/j.ctarc.2026.101422}
}

RIS

TY  - JOUR
TI  - Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis
AU  - Jiann-Hwa Chen
AU  - Chia-Chi Wang
AU  - I-Shiang Tzeng
PY  - 2026
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2026.101422
UR  - https://doi.org/10.1016/j.ctarc.2026.101422
ER  - 

APA

Chen, J., Wang, C., & Tzeng, I. (2026). Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101422

Source records